Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Invion ( (AU:IVX) ) has shared an announcement.
Invion Limited has successfully raised approximately $0.8 million through the issuance of Convertible Notes, primarily backed by Summit Biotech Fund and a specialist microcap fund. The capital raised will be used to settle outstanding obligations with Lind Global Fund II LP and for general working capital. This financial maneuver positions Invion to pursue significant growth opportunities, including securing global licensing agreements for its Photosoft technology platform, which could enhance its industry positioning and stakeholder value.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on developing and commercializing its Photosoft technology platform for therapeutics and diagnostics. The company aims to secure global licensing agreements to expand its market reach.
Average Trading Volume: 112,655
Technical Sentiment Signal: Sell
Current Market Cap: A$8.56M
See more insights into IVX stock on TipRanks’ Stock Analysis page.